Dear Reader,
This issue of Human Vaccines & Immunotherapeutics starts with a robust Coronavirus section, featuring a review of cytokine-targeting antibodies for treatment of Covid-19 (Johnson, p 2824), a study of mortality in Belgian patients treated with statins, ACE inhibitors, and angiotensin receptor blockers (Byttebier, p 2841), a report on the correlation of mortality due to Covid-19 and that due to influenza and tuberculosis (Pathak, p 2851), a trial of pharmacists’ involvement in the vaccination campaign (Wang, p 2863), a survey of legislator online vaccine engagement before and during the pandemic (Engel-Rebitzer, p 2868), a review of the various Covid-19 vaccine platforms (Verdecia, p 2873), reports on vaccination of health-care workers (HCWs) in China (Yu, p 2894), delays of vaccine uptake in US (Latkin, p 2903), intentions to receive the vaccine among reproductive-age women (Berenson, p 2914), parents’ willingness to pay for the vaccine (Catma, p 2919), willingness to receive the vaccine among Chinese HCWs (Wang, p 2926), vaccine knowledge and attitudes in French HCWs (Verger, p 2934), the effect of vaccine effectiveness and safety on acceptance (Wagner, p 2940), vaccine perceptions in a pediatric hospital in Turkey (Yigit, p 2946), vaccine delivery in Nigeria (Sato, p 2951), and a case of reactive arthritis following vaccination (Qin, p 2954), four commentaries on the need to monitor Guillain-Barre syndrome as a vaccine adverse effect (Leung, p 2957), single-dose vaccination in convalescents (Focosi, p 2959), the need to engage HCWs and academics in social media vaccine debates (Hernandez, p 2962), and an experimental OMV-based platform for Covid-19 vaccine (Gaspar, p 2965), and a Letter to the Editor on insights into the safety of the BNT162b2 vaccine (Gringeri, p 2969).
The Immunotherapy segment includes two reviews of checkpoint inhibitors for pleural mesothelioma (Metro, p 2972) and T-cell receptor-like antibody for the treatment of cervical cancer (Dass, p 2981), and a commentary on RNA-based cancer vaccines (Zhang, p 2995).
Eight articles on Acceptance present a survey of public values in relation to vaccinomics (Gerber, p 2999), a bibliometric analysis of four decades of research on vaccine hesitancy (Jaca, p 3016), interview-based study of parents’ barriers to acceptance of childhood vaccines (Musa, p 3023), a comparison of methods for estimating vaccine coverage (Hu, p 3034), assessment of impact of a vaccine event on parental acceptance (Sun, p 3042), surveys of public perceptions of pharmacists as vaccine administrators (Di Castri, p 3052) and parental attitudes to routine pediatric vaccination in Greece (Gkentzi, p 3066), and a commentary on barriers to vaccination in HCWs (Eltvedt, p 3073).
Five studies on HPV investigate ways of communicating recommended age of vaccination (Margolis, p 3077), trends in health-care providers’ vaccine recommendations in US (Domgue, p 3081), vaccine behavior of pharmacists (Koskan, p 3090), ways of promoting vaccination during the period of suspension of government recommendation in Japan (Ugumori, p 3096), and confidence in vaccination among mothers, adolescents, and HCWs (Shuto, p 3102).
We present four articles on Influenza: a report on increased demand for the seasonal vaccine among HCWs during the Covid-19 pandemic (Štěpánek, p 3113), a survey of vaccine preferences among the Chinese elderly (Jiang, p 3119), a study of the impact of vaccination on the risk of contracting Covid-19 (Bozek, p 3126), and an immunogenicity trial of the trivalent vaccine in COPD patients (Li, p 3131).
The Licensed Vaccines section introduces an intervention at school entry to improve varicella vaccination uptake (Qin, p 3137), evaluation of measles vaccine coverage in China (Yang, p 3145), a Letter to the Editor on seroprevalence of mumps antibodies in young adults (Sasaki, p 3153), analysis of rubella seroprevalence and incidence in mothers 3 years after vaccine introduction in Vietnam (Toizumi, p 3156), long-term immunogenicity of booster rabies vaccination (Hu, p 3162), and a report on trends in research on rabies vaccines (Ahmad, p 3169).
Three Public Health articles examine age-appropriate childhood vaccination practices in an Ethiopian pastoral community (Woldu Anbesu, p 3178), risk factors for vaccination delays in Bangladeshi slums (Alam, p 3186), and a novel vaccine monitoring platform for use in large-scale Ebola vaccination campaign (Mc Kenna, p 3192).
The Hepatitis segment reports on B- and T-cell receptor profiles following HBV vaccination of adults (Zhao, p 3203), predicting Hepatitis B vaccine immunogenicity in hemodialysis patients (Feng, p 3214), and bibliometric trends in hepatitis A research (Ahmad, p 3221).
Two Meningococcal studies present an antigen typing system for assessing coverage by the 4CMenB vaccine (Tozer, p 3230), and increasing awareness and uptake of the MenB vaccine among university students (Richardson, p 3239).
Finally, we are happy to feature a Technology review of unsafe injection practices (Ali Khan, p 3247).
Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section, we also regularly publish opinion pieces on timely, interesting, and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles, and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!
Disclosure statement
No potential conflicts of interest were disclosed.
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam Weiss, PhD
Acquisitions Editor